Unnamed: 0,title,date,stock,sentiment
948839.0,"Oragenics Shares Spike As Traders Circulate May 4 Announcement That Co. Will Acquire Noachis Terra, Which Is Developing Coronavirus Vaccine Candidate; Traders Say Co. Hoping To Initiate Trial In First Half Of 2021",2020-05-29 13:54:00-04:00,OGEN,positive
948840.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-05-20 07:16:00-04:00,OGEN,neutral
948841.0,"Oragenics shares are trading higher after the company announced it entered into an agreement with Aragen Biosciences to accelerate the development of TerraCoV2, a potential coronavirus vaccine candidate.",2020-05-19 08:22:00-04:00,OGEN,positive
948842.0,"Oragenics Inc. and Aragen Bioscience Enter Agreement To Accelerate Development of TerraCoV2, A SARS-CoV-2 (COVID 19 Coronavirus) Vaccine Candidate",2020-05-19 08:02:00-04:00,OGEN,positive
948843.0,72 Biggest Movers From Yesterday,2020-05-05 04:29:00-04:00,OGEN,neutral
948844.0,55 Stocks Moving In Monday's Mid-Day Session,2020-05-04 12:39:00-04:00,OGEN,neutral
948845.0,Oragenics shares are trading higher after the company announced it has acquired Noachis Terra to develop its coronavirus vaccine candidate.,2020-05-04 07:08:00-04:00,OGEN,positive
948846.0,30 Stocks Moving in Monday's Pre-Market Session,2020-05-04 07:05:00-04:00,OGEN,neutral
948847.0,"Oragenics Acquires Noachis Terra To Develop Its COVID 19 Vaccine Candidate For $1.93M Cash, 9.2M Shares of Stocks and 9.2M Warrants",2020-05-04 06:15:00-04:00,OGEN,positive
948848.0,H.C. Wainwright Downgrades Oragenics to Neutral,2020-04-16 07:47:00-04:00,OGEN,neutral
948849.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,OGEN,neutral
948850.0,"Oragenics, Inc. Announces Early Top-Line Results of Phase 2 Clinical Trial Of AG013 For Oral Mucositis In Chemoradiation Treatment of Head and Neck Cancer; Trial Did Not Demonstrate Statistical Significance On Its Primary Endpoint",2020-04-15 06:31:00-04:00,OGEN,negative
948851.0,The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations,2020-04-05 14:03:00-04:00,OGEN,neutral
948854.0,Oragenics Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis,2019-12-02 08:33:00-05:00,OGEN,neutral
948855.0,Oragenics Reports Published Peer-Reviewed Study In Journal Of Peptide Science Showing First Complete Clinical Chemical Synthesis Of Bicycle Ring Of Mutacin 1140 Analog,2019-11-15 08:00:00-05:00,OGEN,neutral
948856.0,"Oragenics Highlights Senior VP of Discovery Research, Martin Handfield, Will Be Featured Speaker At International Conference on Microbial Research and Applications Nov. 13, 2019",2019-11-11 10:24:00-05:00,OGEN,neutral
948857.0,Oragenics Granted European Patent Titled 'Variants Of The Lantibiotic MU1140 And Other Lantibiotics With Improved Pharmacological Properties And Structural Features',2019-11-06 12:29:00-05:00,OGEN,positive
948858.0,"The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear",2019-09-29 15:01:00-04:00,OGEN,positive
948859.0,"Oragenics, Inc. Announces Phase 2 Clinical Trial Of AG013 Reaches Enrollment Of 158 Patients",2019-09-25 08:02:00-04:00,OGEN,positive
948860.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,OGEN,neutral
948861.0,Oragenics shares are trading higher after the company offered development updates of AG013 for Oral Mucositis.,2019-05-20 15:07:00-04:00,OGEN,positive
948862.0,Oragenics Offers Development Update Of AG013 For Oral Mucositis,2019-05-20 07:46:00-04:00,OGEN,neutral
948863.0,Oragenics Highlights Publication Of Preclinical Data OF Co.'s OG253 In 'Toxicology and Applied Pharmacology',2019-05-13 09:18:00-04:00,OGEN,neutral
948864.0,Oragenics shares are trading higher after H.C. Wainwright initiated coverage on the stock with a Buy rating and price target of $2 per share.,2019-04-26 09:40:00-04:00,OGEN,positive
948865.0,"H.C. Wainwright Initiates Coverage On Oragenics Inc. Common Stock with Buy Rating, Announces $2 Price Target",2019-04-26 07:45:00-04:00,OGEN,neutral
948866.0,"Top 15 Most-Volatile Stocks For Fri., Mar. 29, 2019 Via Benzinga's Securities Lending Volatility Index Powered By Tidal Markets",2019-03-29 09:32:00-04:00,OGEN,positive
948867.0,Oragenics Reports Entered Collaboration With Florida Int'l. University To Expand Its Pipeline Of Lantibiotics,2019-03-27 08:02:00-04:00,OGEN,positive
948868.0,"Top 15 Most-Volatile Stocks For Tues., Mar. 26, 2019 Via Benzinga's Securities Lending Volatility Index Powered By Tidal Markets",2019-03-26 08:22:00-04:00,OGEN,positive
948869.0,60 Biggest Movers From Yesterday,2019-03-22 05:36:00-04:00,OGEN,neutral
948870.0,Mid-Afternoon Market Update: Dow Surges 250 Points; Micron Shares Gain On Upbeat Earnings,2019-03-21 14:41:00-04:00,OGEN,positive
948871.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-03-21 12:56:00-04:00,OGEN,neutral
948872.0,Mid-Day Market Update: Superconductor Technologies Rises After Q4 Results; Staffing 360 Solutions Shares Slide,2019-03-21 12:09:00-04:00,OGEN,positive
948873.0,Mid-Morning Market Update: Markets Open Higher; Conagra Earnings Top Expectations,2019-03-21 10:12:00-04:00,OGEN,positive
948874.0,Oragenics shares are trading lower after the company priced an offering consisting of 1 share of stock and warrants to purchase 2 shares of stock at $0.75/unit.,2019-03-21 08:50:00-04:00,OGEN,positive
948875.0,"Oragenics Prices ~16.667M Share, Warrants For ~8.33M Shares Offering At $0.75/Share, Warrants",2019-03-21 06:06:00-04:00,OGEN,positive
948876.0,"10 Stocks To Watch For March 21, 2019",2019-03-21 04:32:00-04:00,OGEN,neutral
948877.0,6 Stocks Moving In Wednesday's After-Hours Session,2019-03-20 17:16:00-04:00,OGEN,neutral
948878.0,"Organics Reports Offering Of Common Stock, No Terms Disclosed",2019-03-20 16:40:00-04:00,OGEN,negative
948879.0,60 Biggest Movers From Yesterday,2019-03-19 05:24:00-04:00,OGEN,neutral
948880.0,48 Stocks Moving In Monday's Mid-Day Session,2019-03-18 12:33:00-04:00,OGEN,neutral
948881.0,Oragenics shares are trading higher after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.,2019-03-18 10:07:00-04:00,OGEN,positive
948882.0,"Oragenics, Inc. Announces Enrollment Of 60th Patient In Clinical Trial",2019-03-15 16:17:00-04:00,OGEN,neutral
948883.0,"Oragenics shares are trading higher after the company announced publication of a preclinical study using its OG716, in a peer reviewed journal.",2019-01-28 08:51:00-05:00,OGEN,positive
948884.0,Oragnics Reports Received Further Validation For Lantibiotic Compound OG716,2019-01-28 08:39:00-05:00,OGEN,neutral
948885.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Dec. 3, 2018",2018-12-03 12:17:00-05:00,OGEN,positive
948886.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Fri., Nov. 30, 2018",2018-11-30 11:11:00-05:00,OGEN,positive
948887.0,"Oragenics, Inc. Receives Clearance To Enroll Germany And UK Patients Into Phase 2 Clinical Trial Of AG013 For Oral Mucositis",2018-11-15 16:25:00-05:00,OGEN,neutral
948888.0,46 Biggest Movers From Yesterday,2018-10-18 04:47:00-04:00,OGEN,neutral
948889.0,"10 Hottest Stocks From October 17, 2018",2018-10-17 16:53:00-04:00,OGEN,neutral
948890.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Oct. 17, 2018",2018-10-17 13:45:00-04:00,OGEN,positive
948891.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-10-17 12:49:00-04:00,OGEN,neutral
948892.0,Mid-Morning Market Update: Markets Open Lower; Abbott Laboratories Posts In-Line Q3 Earnings,2018-10-17 10:30:00-04:00,OGEN,negative
948893.0,31 Stocks Moving In Wednesday's Pre-Market Session,2018-10-17 08:06:00-04:00,OGEN,neutral
948894.0,Oragenics shares are up 31% premarket after the company received clearance from The Belgian Health Authority to enroll patients into its Phase 2 clinical trial of AG013 for oral mucositis.,2018-10-17 07:57:00-04:00,OGEN,positive
948895.0,Oragenics Reports Received Clearance To Enroll Patients In Belgium Into Its Phase 2 Trial Of AG013 For Oral Mucositis,2018-10-17 07:30:00-04:00,OGEN,neutral
948896.0,55 Biggest Movers From Yesterday,2018-10-04 05:29:00-04:00,OGEN,neutral
948897.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Oct. 3, 2018",2018-10-03 17:13:00-04:00,OGEN,positive
948898.0,Mid-Afternoon Market Update: Crude Oil Rises 1.75%; VistaGen Therapeutics Shares Spike Higher,2018-10-03 14:32:00-04:00,OGEN,negative
948899.0,43 Stocks Moving In Wednesday's Mid-Day Session,2018-10-03 13:09:00-04:00,OGEN,neutral
948900.0,Mid-Day Market Update: Dow Up 130 Points; Kala Pharmaceuticals Shares Slide,2018-10-03 12:22:00-04:00,OGEN,positive
948901.0,Mid-Morning Market Update: Markets Open Higher; Lennar Earnings Top Expectations,2018-10-03 10:16:00-04:00,OGEN,positive
948902.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-10-03 08:10:00-04:00,OGEN,neutral
948903.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Oct. 2, 2018",2018-10-02 17:55:00-04:00,OGEN,positive
948904.0,7 Stocks Moving In Tuesday's After-Hours Session,2018-10-02 16:39:00-04:00,OGEN,neutral
948905.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 1, 2018",2018-10-01 13:17:00-04:00,OGEN,positive
948906.0,Shares Of Penny Stock Oragenics Up ~7.5% After Hours On ~425K Shares Of Volume; Stock Closed Up 46% At $0.70,2018-09-21 16:40:00-04:00,OGEN,positive
948907.0,"Stocks Which Set New 52-Week Low Yesterday, August 16th",2018-08-17 10:40:00-04:00,OGEN,negative
948908.0,55 Stocks Moving In Wednesday's Mid-Day Session,2018-08-15 12:40:00-04:00,OGEN,neutral
948909.0,30 Stocks Moving In Wednesday's Pre-Market Session,2018-08-15 08:11:00-04:00,OGEN,neutral
948910.0,"Oragenics, Inc. Resumes Phase 2 Clinical Trial Of AG013 In Oral Mucositis Following Positive Routine Safety Review",2018-08-15 07:31:00-04:00,OGEN,positive
948911.0,"Stocks Which Set New 52-Week Lows Friday, August 3rd",2018-08-06 13:20:00-04:00,OGEN,negative
948912.0,"Stocks Which Set New 52-Week Low Yesterday, August 2nd",2018-08-03 11:22:00-04:00,OGEN,negative
948913.0,"Stocks Which Set New 52-Week Lows Yesterday, July 24th:",2018-07-25 12:17:00-04:00,OGEN,negative
948914.0,38 Biggest Movers From Friday,2018-07-16 04:47:00-04:00,OGEN,neutral
948915.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Biocept Shares Surge On Marketing Agreement For Proprietary Liquid Biopsy Tests,2018-07-13 14:30:00-04:00,OGEN,positive
948916.0,30 Stocks Moving In Friday's Mid-Day Session,2018-07-13 12:38:00-04:00,OGEN,neutral
948917.0,Mid-Day Market Update: Dow Rises 100 Points; Auris Medical Shares Slide,2018-07-13 12:14:00-04:00,OGEN,positive
948918.0,Mid-Morning Market Update: Markets Mostly Flat; JPMorgan Profit Beats Estimates,2018-07-13 10:11:00-04:00,OGEN,positive
948919.0,Oragenics Shares Fall 30.1% Premarket After Co. Announced Pricing $12M Public Offering,2018-07-13 09:28:00-04:00,OGEN,positive
948920.0,"Oragenics, Inc. Announces Pricing of $12M Underwritten Public Offering",2018-07-13 08:18:00-04:00,OGEN,neutral
948921.0,Oragenics Shares Up 6.5%; Traders Circulating Word Zacks Research Initiated Coverage On Stock With $7 Price Target; BZ NOTE: Zacks Research Calls Do Not Normally Move Stocks Greatly,2018-06-11 10:49:00-04:00,OGEN,positive
948922.0,58 Biggest Movers From Yesterday,2018-06-01 04:47:00-04:00,OGEN,neutral
948923.0,44 Stocks Moving In Thursday's Mid-Day Session,2018-05-31 12:42:00-04:00,OGEN,neutral
948924.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of May 31, 2018",2018-05-31 11:48:00-04:00,OGEN,positive
948925.0,41 Biggest Movers From Yesterday,2018-05-31 04:45:00-04:00,OGEN,neutral
948926.0,Mid-Afternoon Market Update: Dow Rises Over 1%; Dick's Sporting Goods Shares Jump Following Earnings Beat,2018-05-30 14:31:00-04:00,OGEN,positive
948927.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-05-30 12:26:00-04:00,OGEN,neutral
948928.0,Oragenics Shares Up 50.8% Premarket After Co.'s AG013 For Oral Mucositis In Head And Neck Cancer Patients Showed Favorable Safety Profile In Mid-Stage OM Study,2018-05-30 09:12:00-04:00,OGEN,positive
948929.0,Oragenics Reports Positive Interim Safety Analysis Results from Its Phase 2 Clinical Trial of AG013 for Oral Mucositis,2018-05-30 07:51:00-04:00,OGEN,positive
948930.0,Oragenics Shares Down 6.4% Premarket; Shares Spiked Wednesday After Co. Received US Patent For Lantibiotic MU1140,2018-05-24 09:21:00-04:00,OGEN,positive
948931.0,"Oragenics Shares Up 30% Since 2 p.m. EDT Press Release Highlighting Co., Texas A&M University Were Granted US Patent For Lantibiotic MU1140",2018-05-23 14:22:00-04:00,OGEN,positive
948932.0,Watch Oragenics As Traders Circulate USPTO Document Granting The Co. A Patent Related To 'Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features',2018-05-08 10:52:00-04:00,OGEN,positive
948933.0,"Benzinga Pro's Most-Searched Tickers For Afternoon Of Thurs., Apr. 26, 2018",2018-04-26 12:36:00-04:00,OGEN,neutral
948934.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Wed., Apr. 25, 2018",2018-04-25 10:14:00-04:00,OGEN,neutral
948935.0,"Oragenics Resumes Trade, Now Down To $2.09/Share",2018-04-06 14:52:00-04:00,OGEN,neutral
948936.0,Oragenics Prices 900K Share Offering At $2/Share,2018-04-06 14:26:00-04:00,OGEN,positive
948937.0,"Oragenics Shares Halted, Up 22%, News Pending",2018-04-06 14:11:00-04:00,OGEN,positive
948938.0,25 Stocks Moving In Monday's Pre-Market Session,2018-03-19 08:01:00-04:00,OGEN,neutral
948939.0,46 Biggest Movers From Yesterday,2018-03-13 05:38:00-04:00,OGEN,neutral
948940.0,44 Biggest Movers From Friday,2018-03-12 04:59:00-04:00,OGEN,neutral
948941.0,36 Stocks Moving In Friday's Mid-Day Session,2018-03-09 12:41:00-05:00,OGEN,neutral
948942.0,56 Biggest Movers From Yesterday,2018-03-09 04:51:00-05:00,OGEN,neutral
948943.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-03-08 12:31:00-05:00,OGEN,neutral
948944.0,"Benzinga Pro's Top 10 Most-Searched Tickers On Thurs., Mar. 8",2018-03-08 09:10:00-05:00,OGEN,positive
948945.0,32 Stocks Moving In Thursday's Pre-Market Session,2018-03-08 08:06:00-05:00,OGEN,neutral
948946.0,"Several Low-Float Stocks Seeing Significant Volatility Wed.: Zosano Pharma Shares Up 61% (2M Shares Outstanding), Oragenics Up 47% (5M Shares Outstanding), Innovate Down 7% For Session, Up 15% From Lows (14M Shares), OpGen Down 14% From Highs (5M Shares)",2018-03-07 14:41:00-05:00,OGEN,positive
948947.0,"Oragenics Shares Pullback Sharply From Highs Over Last Few Mins; Stock Had Traded Up As Much As 100% On No News; Shares Now Up 60% For Session; BZ NOTE: This May Be Being Viewed As A Low-Float Momentum Play, Has ~4.93M Shares Outstanding",2018-03-07 10:20:00-05:00,OGEN,positive
948948.0,"Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation",2018-02-20 16:46:00-05:00,OGEN,neutral
948949.0,33 Biggest Movers From Yesterday,2018-02-06 05:09:00-05:00,OGEN,neutral
948950.0,38 Biggest Movers From Yesterday,2018-01-30 04:37:00-05:00,OGEN,neutral
948951.0,35 Stocks Moving In Monday's Mid-Day Session,2018-01-29 12:21:00-05:00,OGEN,neutral
948952.0,41 Stocks Moving In Friday's Mid-Day Session,2018-01-26 13:04:00-05:00,OGEN,neutral
948953.0,44 Biggest Movers From Yesterday,2018-01-26 04:43:00-05:00,OGEN,neutral
948954.0,34 Stocks Moving In Thursday's Mid-Day Session,2018-01-25 13:29:00-05:00,OGEN,neutral
948955.0,"Oragenics Shares Halted On Circuit Breaker, Up 54%",2018-01-25 09:36:00-05:00,OGEN,positive
948956.0,"Oragenics Shares Resume Trade, Not Yet Seeing Updated Last Price",2018-01-24 12:26:00-05:00,OGEN,positive
948957.0,UPDATE: Not Seeing News On Oragenics Which Would Account For Sharp Upside; Stock May Be Considered Low-Float Play As Has ~5M Shares Outstanding,2018-01-24 12:22:00-05:00,OGEN,positive
948958.0,"Oragenics Shares Halted On Circuit Breaker, Up 35.8%",2018-01-24 12:21:00-05:00,OGEN,positive
948959.0,A Peek Into The Markets: U.S. Stock Futures Mostly Flat Ahead Of Fed Speakers,2018-01-08 07:32:00-05:00,OGEN,neutral
948960.0,"Oragenics, Inc. Announces 1-For-10 Reverse Stock Split",2018-01-08 07:15:00-05:00,OGEN,neutral
948961.0,"Oragenics Reports Closing Of $3.3M Preferred Stock Private Placement, $3.4M Debt Conversion Into Equity; Reports Amendment to Exclusive Channel Collaboration Deals With Intrexon",2017-11-09 07:29:00-05:00,OGEN,negative
948962.0,Oragenics Shares Halted News Pending,2017-11-09 06:59:00-05:00,OGEN,positive
948963.0,Oragenics Reports Dosing Of First Patient In Phase 2 Trial Of AG013 For Oral Mucositis,2017-08-31 07:31:00-04:00,OGEN,neutral
948964.0,Oragenics Reports $3.0M Preferred Stock Private Placement and $2.4M Loan,2017-05-11 07:46:00-04:00,OGEN,neutral
948965.0,"Oragenics Shares Open For Trade, Now Up 6.52% Or $0.025/Share",2017-04-18 13:43:00-04:00,OGEN,positive
948966.0,Oragenics Halted News Pending,2017-04-18 12:35:00-04:00,OGEN,neutral
948967.0,8-K Filing Shows Oragenics Board Authorized To Issue Add'l 100K Shares Common Stock,2017-01-13 16:24:00-05:00,OGEN,positive
948968.0,Oragenics CEO Letter Says Preparing to Advance Leading Drug Candidate for Phase 2 Trial and Investigational New Drug Application,2017-01-04 07:48:00-05:00,OGEN,neutral
948969.0,Oragenics Reports Fast Track Designation For AG013 Has Been Granted By The FDA,2016-11-21 15:35:00-05:00,OGEN,positive
948970.0,Oragenics Receives Supportive FDA Feedback for Initiating a Phase 2 Study Protocol for Oral Mucositis Treatment,2016-08-30 08:15:00-04:00,OGEN,positive
948971.0,Oragenics To Sell Consumer Probiotic Business For $1.7M Cash,2016-06-23 08:03:00-04:00,OGEN,neutral
948972.0,Oragenics Announces Alan Joslyn As new President And CEO & Board Member,2016-06-06 16:52:00-04:00,OGEN,neutral
948973.0,Oragenics Announces Positive Results from Confirmatory Animal Study of AG013 for Treatment of Oral Mucositis and Plans to Finalize Phase 2 Clinical Trial Protocol,2016-05-02 16:46:00-04:00,OGEN,positive
948974.0,Oragenics Receives New Patent for Improved Replacement Therapy for Dental Caries,2016-02-19 08:15:00-05:00,OGEN,positive
948975.0,Morning Market Losers,2015-09-29 10:02:00-04:00,OGEN,negative
948976.0,Oragenics Announces Positive Results of an Independent ProBiora3 Study,2015-09-29 08:15:00-04:00,OGEN,positive
948977.0,Oragenics Spikes Higher,2015-08-03 15:58:00-04:00,OGEN,neutral
948978.0,Morning Market Gainers,2015-07-29 09:46:00-04:00,OGEN,neutral
948979.0,Oragenics Announce Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study,2015-07-28 16:38:00-04:00,OGEN,positive
948980.0,"Intrexon, Oragenics Increase Partnership To Pursue Biotherapeutic Developments For The Oral Cavity",2015-06-10 08:16:00-04:00,OGEN,positive
948981.0,Anended 13G: Koski Family Limited Partnership Reports 34.7% Stake In Oragenics Inc,2015-01-23 16:11:00-05:00,OGEN,negative
948982.0,"Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business",2014-12-22 16:55:00-05:00,OGEN,neutral
948983.0,"Exclusive: Oragenics CEO John Bonfiglio Talks Intrexon, Lantibiotics",2014-06-10 15:40:00-04:00,OGEN,positive
948984.0,Oragenics Announces Large Number of New Potential Analogs Generated from Mutacin 1140 lantibiotic Program Platform,2014-05-06 07:57:00-04:00,OGEN,positive
948985.0,Oragenics Declines Comment on Unusual Market Activity ,2014-01-13 14:44:00-05:00,OGEN,neutral
948986.0,Oragenics Resumes Trading,2014-01-13 12:10:00-05:00,OGEN,neutral
948987.0,Oragenics Halted on Circuit Breaker,2014-01-13 12:06:00-05:00,OGEN,neutral
948988.0,"Oragenics to Offer 4.4M Shares at $2.50/Share, Sees Gross Proceeds of $11M",2013-11-15 09:25:00-05:00,OGEN,negative
948989.0,"Oragenics, Intrexon Announce Deal to Develop Genetically Modified Probiotics, Intrexon Invests $3.9M in Oragenics",2013-10-01 09:39:00-04:00,OGEN,neutral
